DOI:
10.1055/s-00000139
Notfallmedizin up2date
LinksClose Window
References
Kloner RA, Goldstein I, Kirby MG. et al.
Cardiovascular safety of phosphodiesterase type 5 inhibitors after nearly 2 decades on the market.
Sex Med Rev 2018;
DOI: 10.1016/j.sxmr.2018.03.008.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.